BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2862703)

  • 1. [Antihypertensive pharmacotherapy with the vasodilators captopril and endralazine].
    Hartmann HG; Schumacher H
    Schweiz Med Wochenschr; 1985 Jul; 115(27-28):939-44. PubMed ID: 2862703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of refractory hypertension with combined minoxidil and captopril in low doses].
    Palatini P; Pessina AC; Sperti G; Fortunato V; Gava R; Dal Palù C
    G Ital Cardiol; 1984 Jun; 14(6):401-6. PubMed ID: 6148288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
    Hauger-Klevene JH; Reader C; Mayer E; Sanchez MR
    Int J Clin Pharmacol Res; 1986; 6(4):275-81. PubMed ID: 3531038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term captopril treatment of severe hypertension resistant to tritherapy.
    Ectors M; Staroukine M; Demanet JC
    Acta Clin Belg; 1982; 37(2):59-64. PubMed ID: 6126060
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute titration and chronic follow-up with captopril in hypertension. A one-year safety profile on combination therapy with captopril and a diuretic.
    Mahapatra D; Mahapatra RK; Yaden S; Hunter KW
    Angiology; 1986 Dec; 37(12 Pt 1):865-79. PubMed ID: 2880534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic.
    van Brummelen P; Bühler FR; Kiowski W; Bolli P; Bertel O
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):380-5. PubMed ID: 40887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)].
    Kindler J; Glöckner WM; Sieberth HG; Konrads A; Meurer KA; Schulz V; Vaith P
    Dtsch Med Wochenschr; 1981 Sep; 106(37):1176-81. PubMed ID: 7343274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe arterial hypertension with propyldazine (ISF 2123) associated with a diuretic and a beta-blocking agent].
    Angelino PF; Lavezzaro G; Carnovali M
    Minerva Cardioangiol; 1979 Mar; 27(3):113-8. PubMed ID: 37462
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined captopril treatment in severe and moderately severe hypertension resistant to therapy.
    Sallai G
    Acta Physiol Hung; 1988; 72 Suppl():45-50. PubMed ID: 3075402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effective blood pressure reduction and few side-effects in treatment with captopril and diuretics].
    Nilsson O; Karlberg BE; Wettre S; Ohman P; Andersson PO; Engström M; Kuylenstierna J; Ottosson AM; Sjöstrand A
    Lakartidningen; 1985 Jun; 82(26-27):2430-3. PubMed ID: 3892203
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained antihypertensive effect of captopril combined with diuretics and beta-adrenergic blocking drugs in patients with resistant hypertension.
    Forslund T; Fyhrquist F; Hortling L
    Acta Med Scand; 1983; 213(4):299-303. PubMed ID: 6137132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of captopril (Tensiomin) in patients with hypertension.
    Török E; Bíró V; Wagner M; Kósa E; Podmaniczky M; Cseh K
    Acta Physiol Hung; 1988; 72 Suppl():51-65. PubMed ID: 2908092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group.
    Mirkin BL; Newman TJ
    Pediatrics; 1985 Jun; 75(6):1091-100. PubMed ID: 3889818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril as a replacement for multiple therapy in hypertension: a controlled study.
    Yodfat Y; Fidel J; Bloom DS
    J Hypertens Suppl; 1985 Nov; 3(2):S155-8. PubMed ID: 3910775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.